1. Home
  2. ESE vs BLCO Comparison

ESE vs BLCO Comparison

Compare ESE & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESE
  • BLCO
  • Stock Information
  • Founded
  • ESE 1990
  • BLCO 1853
  • Country
  • ESE United States
  • BLCO Canada
  • Employees
  • ESE N/A
  • BLCO N/A
  • Industry
  • ESE Telecommunications Equipment
  • BLCO Ophthalmic Goods
  • Sector
  • ESE Telecommunications
  • BLCO Health Care
  • Exchange
  • ESE Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • ESE 5.4B
  • BLCO 4.9B
  • IPO Year
  • ESE N/A
  • BLCO 2022
  • Fundamental
  • Price
  • ESE $210.48
  • BLCO $14.89
  • Analyst Decision
  • ESE Strong Buy
  • BLCO Hold
  • Analyst Count
  • ESE 2
  • BLCO 11
  • Target Price
  • ESE $187.50
  • BLCO $15.80
  • AVG Volume (30 Days)
  • ESE 235.2K
  • BLCO 512.5K
  • Earning Date
  • ESE 11-13-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • ESE 0.15%
  • BLCO N/A
  • EPS Growth
  • ESE 14.55
  • BLCO N/A
  • EPS
  • ESE 4.43
  • BLCO N/A
  • Revenue
  • ESE $1,123,852,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • ESE $17.55
  • BLCO $8.27
  • Revenue Next Year
  • ESE $12.43
  • BLCO $5.73
  • P/E Ratio
  • ESE $47.19
  • BLCO N/A
  • Revenue Growth
  • ESE 22.39
  • BLCO 8.81
  • 52 Week Low
  • ESE $118.96
  • BLCO $10.45
  • 52 Week High
  • ESE $211.25
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • ESE 65.50
  • BLCO 53.33
  • Support Level
  • ESE $200.19
  • BLCO $15.00
  • Resistance Level
  • ESE $210.79
  • BLCO $15.50
  • Average True Range (ATR)
  • ESE 4.68
  • BLCO 0.35
  • MACD
  • ESE 0.81
  • BLCO -0.01
  • Stochastic Oscillator
  • ESE 95.52
  • BLCO 43.22

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: